Table 1 Demographics and comorbidities
Ad libitum clears | Usual Care | Difference | |||
|---|---|---|---|---|---|
Patients in each study arm | 90 | 49.7% | 91 | 50.3% | -0.55% |
Planned Procedure—n (%) | |||||
Transcatheter Aortic Valve Replacement | 21 | 23.3% | 24 | 26.4% | -3.0% |
Arrhythmia Ablation | 69 | 76.7% | 67 | 73.6% | 3.0% |
Sex (Male)- n (%) | 58 | 64.4% | 63 | 69.2% | -4.8% |
Age—mean (SD) | 68.1 | 11.8 | 68.9 | 11.5 | -0.8 |
Race- n (%) | |||||
Asian | 1 | 1.1% | 1 | 1.1% | 0.0% |
Black/African American | 4 | 4.4% | 2 | 2.2% | 2.2% |
White | 85 | 94.4% | 87 | 95.6% | -1.2% |
Other | 0 | 0.0% | 1 | 1.1% | -1.1% |
Smoking Status- n (%) | |||||
Current | 11 | 12.2% | 6 | 6.6% | 5.6% |
Former | 46 | 51.1% | 44 | 48.4% | 2.8% |
Never | 33 | 36.7% | 41 | 45.1% | -8.4% |
Hypertension—n (%) | 66 | 73.3% | 68 | 74.7% | -1.4% |
Previous PONV- n (%) | 7 | 7.8% | 1 | 1.1% | 6.7%a |
Chronic Obstructive Lung Disease- n (%) | 7 | 7.8% | 8 | 8.8% | -1.0% |
Home Oxygen- n (%) | 2 | 2.2% | 0 | 0.0% | 2.2% |
Coronary Artery Disease- n (%) | 26 | 28.9% | 21 | 23.1% | 5.8% |
Stent | 20 | 22.2% | 14 | 15.4% | 6.8% |
CABG | 9 | 10% | 9 | 9.9% | 0.1% |
Medically managed | 1 | 1.1% | 2 | 2.2% | -1.1% |
Unknown | 1 | 1.1% | 1 | 1.1% | 0.0% |
Diabetes- n (%) | 21 | 23.3% | 20 | 22% | 1.4% |
Diet | 3 | 3.3% | 2 | 2.2% | 1.1% |
Insulin | 5 | 5.6% | 4 | 4.4% | 1.2% |
Oral | 12 | 13.3% | 14 | 15.4% | -2.1% |
Unknown | 1 | 1.1% | 0 | 0.0% | 1.1% |
Congestive Heart Failure Class- n (%) | 34 | 37.8% | 47 | 51.6% | -13.9% |
I | 4 | 4.4% | 7 | 7.7% | -3.2% |
II | 11 | 12.2% | 16 | 17.6% | -5.4% |
III | 17 | 18.9% | 22 | 24.2% | -5.3% |
IV | 2 | 2.2% | 1 | 1.1% | 1.1% |
Unknown | 0 | 0.0% | 1 | 1.1% | -1.1% |
Chronic Kidney Disease Class- n (%) | 16 | 17.8% | 15 | 16.5% | 1.3% |
III | 4 | 4.4% | 7 | 7.7% | -3.2% |
IIIB | 8 | 8.9% | 3 | 3.3% | 5.6% |
IV | 2 | 2.2% | 3 | 3.3% | -1.1% |
V | 1 | 1.1% | 2 | 2.2% | -1.1% |
Unknown | 1 | 1.1% | 0 | 0.0% | 1.1% |
Obstructive Sleep Apnea- n (%) | 13 | 14.4% | 27 | 29.7% | -15.2%a |
CPAP | 8 | 8.9% | 13 | 14.3% | -5.4% |
GERD/Reflux- n (%) | 23 | 25.6% | 25 | 27.5% | -1.9% |
No treatment | 7 | 7.8% | 3 | 3.3% | 4.5% |
Proton Pump Inhibitor | 13 | 14.4% | 19 | 20.9% | -6.4% |
Histamine 2 Blocker | 1 | 1.1% | 3 | 3.3% | -2.2% |
Unknown | 2 | 2.2% | 0 | 0.0% | 2.2% |
Glucose—median (IQR) | 99 | (88, 112) | 103 | (90, 166) | -2 |
Blood Urea Nitrogen—median (IQR) | 19 | (15, 25) | 19 | (15, 23) | 0 |
Creatinine—median (IQR) | 1 | (0.8, 1.2) | 1 | (0.8, 1.2) | -0.1 |
Glomerular Filtration Rate—mean (std) | 73.5 | 22.7 | 70.1 | 21.1 | 3.4 |
Hemoglobin—mean (std) | 13.7 | 1.7 | 13.7 | 2 | 0.02 |
Complete ECHO Report in last 6 mo- n (%) | 62 | 68.9% | 62 | 68.1% | 0 |
LVEF—median (IQR) | 60.5 | (50, 65) | 60 | (50, 65) | 1 |
LVEF Category—n (%) | |||||
Normal | 44 | 48.9% | 42 | 46.2% | 2.7% |
Mildly reduced | 10 | 11.1% | 13 | 14.3% | -3.2% |
Moderately Reduced | 3 | 3.3% | 4 | 4.4% | -1.1% |
Severely reduced | 5 | 5.6% | 2 | 2.2% | 3.4% |
Unknown | 0 | 0.0% | 1 | 1.1% | -1.1% |